Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3054)
All Articles published online
|
Mar 28, 2005 (publication date) through Nov 8, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Qian HL, Peng XX, Chen SH, Ye HM, Qiu JH. p62 expression in primary carcinomas of the digestive system. World J Gastroenterol 2005; 11(12): 1788-1792 [PMID: 15793865 DOI: 10.3748/wjg.v11.i12.1788] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v11/i12/1788.htm |
| Number | Citing Articles |
| 1 |
Shinichi Aishima, Nobuhiro Fujita, Yohei Mano, Tomohiro Iguchi, Akinobu Taketomi, Yoshihiko Maehara, Yoshinao Oda, Masazumi Tsuneyoshi. p62+ Hyaline Inclusions in Intrahepatic Cholangiocarcinoma Associated With Viral Hepatitis or Alcoholic Liver Disease. American Journal of Clinical Pathology 2010; 134(3): 457 doi: 10.1309/AJCP53YVVJCNDZIR
|
| 2 |
Dan Sun, Xiaoting Li, Yingjian He, Wenhui Li, Ying Wang, Huan Wang, Shanshan Jiang, Yan Xin. YAP1 enhances cell proliferation, migration, and invasion of gastric cancer in vitro and in vivo. Oncotarget 2016; 7(49): 81062 doi: 10.18632/oncotarget.13188
|
| 3 |
Yongwu Chen, Chongwei Wang, Hui Yang, Ping Huang, Jiana Shi, Yongxi Tong, Jinying Jiang, Xin Zhang, Wanyuan Chen, Zixue Xuan, Wei Lei. Epidemiology of Drug- and Herb-Induced Liver Injury Assessed for Causality Using the Updated RUCAM in Two Hospitals from China. BioMed Research International 2021; 2021: 1 doi: 10.1155/2021/8894498
|
| 4 |
Helmut Denk, Conny Stumptner, Peter M. Abuja, Kurt Zatloukal. Sequestosome 1/p62-related pathways as therapeutic targets in hepatocellular carcinoma. Expert Opinion on Therapeutic Targets 2019; 23(5): 393 doi: 10.1080/14728222.2019.1601703
|
| 5 |
Francesca Mariotti, Gian Enrico Magi, Alessandra Gavazza, Silvia Vincenzetti, Andrey Komissarov, Alex Shneider, Franco Maria Venanzi. p62/SQSTM1 expression in canine mammary tumours: Evolutionary notes. Veterinary and Comparative Oncology 2019; 17(4): 570 doi: 10.1111/vco.12523
|
| 6 |
Chandra B. Lebovitz, Svetlana B. Bortnik, Sharon M. Gorski. Here, There Be Dragons: Charting Autophagy-Related Alterations in Human Tumors. Clinical Cancer Research 2012; 18(5): 1214 doi: 10.1158/1078-0432.CCR-11-2465
|
| 7 |
Ricardo Iserhard, Emily Ferreira Salles Pilar, Francine Hehn de Oliveira, Sidia Maria Callegari-Jacques, Paula Ferst, Fernanda Visioli, Antonio Barros Lopes, Patrícia Luciana da Costa Lopez, Eduardo Cremonese Filippi-Chiela. Autophagy and nuclear morphometry are associated with histopathologic features in esophageal squamous cell carcinoma. Journal of Molecular Medicine 2024; 102(1): 39 doi: 10.1007/s00109-023-02387-4
|
| 8 |
Euthymios Dimitriadis, Theoni Trangas, Stavros Milatos, Periklis G. Foukas, Ioannis Gioulbasanis, Nelly Courtis, Finn C. Nielsen, Nikos Pandis, Urania Dafni, Georgia Bardi, Panayotis Ioannidis. Expression of oncofetal RNA‐binding protein CRD‐BP/IMP1 predicts clinical outcome in colon cancer. International Journal of Cancer 2007; 121(3): 486 doi: 10.1002/ijc.22716
|
| 9 |
Stephan Laggai, Sonja M. Kessler, Stefan Boettcher, Valérie Lebrun, Katja Gemperlein, Eva Lederer, Isabelle A. Leclercq, Rolf Mueller, Rolf W. Hartmann, Johannes Haybaeck, Alexandra K. Kiemer. The IGF2 mRNA binding protein p62/IGF2BP2-2 induces fatty acid elongation as a critical feature of steatosis. Journal of Lipid Research 2014; 55(6): 1087 doi: 10.1194/jlr.M045500
|
| 10 |
Amr Abdel-Moety, Nahed Baddour, Perihan Salem, Hesham El-Tobgy, Assem El-Shendidi. SQSTM1 Expression in Hepatocellular Carcinoma and Relation to Tumor Recurrence After Radiofrequency Ablation. Journal of Clinical and Experimental Hepatology 2022; 12(3): 774 doi: 10.1016/j.jceh.2021.12.001
|
| 11 |
Pavel Strnad, Renwar Nuraldeen, Nurdan Guldiken, Daniel Hartmann, Vineet Mahajan, Helmut Denk, Johannes Haybaeck. Comprehensive Physiology. 2013; : 1393 doi: 10.1002/cphy.c120032
|
| 12 |
Shun Nakayama, Hideaki Karasawa, Takashi Suzuki, Shinichi Yabuuchi, Kiyoshi Takagi, Takashi Aizawa, Yoshiaki Onodera, Yasuhiro Nakamura, Mika Watanabe, Fumiyoshi Fujishima, Hiroshi Yoshida, Takanori Morikawa, Tomohiko Sase, Takeshi Naitoh, Michiaki Unno, Hironobu Sasano. p62/sequestosome 1 in human colorectal carcinoma as a potent prognostic predictor associated with cell proliferation. Cancer Medicine 2017; 6(6): 1264 doi: 10.1002/cam4.1093
|
| 13 |
Eun Mi Je, Nam Jin Yoo, Sug Hyung Lee. Alteration of p62/SQSTM1 Expression Is Uncommon in Gastrointestinal and Prostate Cancer Tissues. Gut and Liver 2013; 7(5): 625 doi: 10.5009/gnl.2013.7.5.625
|
| 14 |
Qiong Wu, Manlin Xiang, Kun Wang, Zhen Chen, Lu Long, Ya Tao, Yunlai Liang, Yahui Yan, Zhiqiang Xiao, Shiyang Qiu, Bin Yi. Overexpression of p62 Induces Autophagy and Promotes Proliferation, Migration and Invasion of Nasopharyngeal Carcinoma Cells through Promoting ERK Signaling Pathway. Current Cancer Drug Targets 2020; 20(8): 624 doi: 10.2174/1568009620666200424145122
|
| 15 |
Huimei Yu, Jing Su, Ye Xu, Jinsong Kang, Hongyan Li, Ling Zhang, Haowei Yi, Xiyan Xiang, Fei Liu, Liankun Sun. p62/SQSTM1 involved in cisplatin resistance in human ovarian cancer cells by clearing ubiquitinated proteins. European Journal of Cancer 2011; 47(10): 1585 doi: 10.1016/j.ejca.2011.01.019
|
| 16 |
Lifeng Feng, Yanning Ma, Jie Sun, Qi Shen, Leiming Liu, Haiqi Lu, Faliang Wang, Yongfang Yue, Jiaqiu Li, Shenjie Zhang, Xiaoying Lin, Jue Chu, Weidong Han, Xian Wang, Hongchuan Jin. YY1-MIR372-SQSTM1 regulatory axis in autophagy. Autophagy 2014; 10(8): 1442 doi: 10.4161/auto.29486
|
| 17 |
Anish Babu, Qi Wang, Ranganayaki Muralidharan, Manish Shanker, Anupama Munshi, Rajagopal Ramesh. Chitosan Coated Polylactic Acid Nanoparticle-Mediated Combinatorial Delivery of Cisplatin and siRNA/Plasmid DNA Chemosensitizes Cisplatin-Resistant Human Ovarian Cancer Cells. Molecular Pharmaceutics 2014; 11(8): 2720 doi: 10.1021/mp500259e
|
| 18 |
J Moscat, M T Diaz-Meco, M W Wooten. Of the atypical PKCs, Par-4 and p62: recent understandings of the biology and pathology of a PB1-dominated complex. Cell Death & Differentiation 2009; 16(11): 1426 doi: 10.1038/cdd.2009.119
|